www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
China / Society

Stem-cell trials give new hope to heart patients

By Shan Juan (China Daily) Updated: 2014-08-26 06:53

China's patients with chronic heart failure - a serious and common condition in which the heart cannot pump enough blood - will soon have access to the stem-cell-based therapy C-Cure.

Eight to 10 trial sites are expected to be set up at renowned public medical institutions in Beijing, Shanghai and Guangzhou, in addition to others around the world, to test the safety and effectiveness of the therapy.

"Participating in the trial will enhance the stem-cell research capacity of China, which remains uncompetitive worldwide," said Zhou Yujie, vice-president of Beijing Anzhen hospital.

It is the first stem-cell therapy for cardiology to enter Phase 3 of a clinical trial in China, he noted.

Chronic heart failure affects about 117 million people worldwide, including nearly 30 million in China, according to the World Health Organization and China's National Health and Family Planning Commission.

Current treatments mainly work to slow down progression of the disease, but with the exception of heart transplants they cannot cure the disease, said professor Gu Hong of Anzhen hospital.

"C-Cure is a revolutionary stem-cell treatment for heart failure. If it passes the Phase 3 clinical trial, it will enter the market to save the patients," she said.

The therapy reprograms the patient's own stem cells into new heart cells to rebuild the heart, according to Atta Behfar, director of cardiovascular regeneration at Mayo Clinic in the US.

He has played an active part in developing the technology that directs the patient's cells to become heart cells. Mayo Clinic was also involved in previous clinical trials of C-Cure in the United States.

"Stem-cell therapy aims to teach the human body to heal itself and we're moving gradually from promise to reality," he said.

Xu Guotong, head of the medicine department of Tongji Medical University in Shanghai, agreed but pointed out that China still lags far behind the US.

"The problem lies in a lack of government regulations and policies," he acknowledged.

Between a drug and a therapy, stem-cell treatment needs to be clearly defined by the health and drug authorities in China, he said.

shanjuan@chinadaily.com.cn

Highlights
Hot Topics
...
主站蜘蛛池模板: 欧美一区二区在线观看免费网站 | 午夜精品亚洲 | 国产97视频在线 | 亚洲免费在线视频观看 | 欧美成国产精品 | 国产成人高清精品免费5388密 | 国产亚洲精品久久久久久 | 久久久久久久99精品免费观看 | 日韩欧美亚洲每的更新在线 | 俺来也俺来也天天夜夜视频 | 国产精品成久久久久三级 | 久草久视频| 国内精品一区二区三区最新 | 国产91丝袜在线播放九色 | 亚洲厕拍 | 亚洲欧美自拍视频 | 成人午夜大片 | 97免费在线观看视频 | 亚洲精品在线影院 | 一本久道久久综合婷婷 | 成人中文字幕在线观看 | 亚洲在线网站 | 久久视频在线观看免费 | 中文字幕综合在线 | 欧美亚洲国产精品 | 一级特黄aa大片欧美 | 87精品福利视频在线观看 | 免费看一级欧美激情毛片 | 免费一区二区三区久久 | 久久久久久国产精品免费免 | 成人亚洲国产 | 真实偷清晰对白在线视频 | 国产精品人成人免费国产 | 亚洲一级视频在线观看 | 欧美成人午夜毛片免费影院 | 午夜a一级毛片一.成 | 国产成年网站v片在线观看 国产成人aa在线视频 | 免费看成人频视在线视频 | 曰韩一级毛片 | 亚洲久久网 | 久久精品国产精品亚洲毛片 |